0001237899-12-000013.txt : 20120111
0001237899-12-000013.hdr.sgml : 20120111
20120111175539
ACCESSION NUMBER: 0001237899-12-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120110
FILED AS OF DATE: 20120111
DATE AS OF CHANGE: 20120111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Terifay Robert J
CENTRAL INDEX KEY: 0001391382
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 12522841
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0304
4
2012-01-10
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001391382
Terifay Robert J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Commercial
Common Stock
2012-01-10
4
M
0
18128
21.34
A
27500
D
Common Stock
2012-01-10
4
F
0
5233
73.92
D
22267
D
Common Stock
2012-01-10
4
F
0
4651
73.92
D
17616
D
Common Stock
2012-01-10
4
M
0
1872
21.92
A
19488
D
Common Stock
2012-01-10
4
F
0
554
73.92
D
18934
D
Common Stock
2012-01-10
4
F
0
543
73.92
D
18391
D
Common Stock
2012-01-11
4
S
0
9019
74.2
D
9372
D
Common Stock
1387
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
21.34
2012-01-10
4
M
0
18128
D
2017-02-26
Common Stock
18128
0
D
Non-Qualified Stock Option (right to buy)
21.92
2012-01-10
4
M
0
1872
D
2017-12-17
Common Stock
1872
35628
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 9,019 shares of Company stock on January 11, 2012 at prices ranging from $74.10 to $74.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 11, 2012 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Robert J. Terifay
2012-01-11